Ads
related to: nivolumab- View Dosing Schedules
Find Dosing Information For This
Treatment Option Today.
- View Efficacy Data
Explore Efficacy & Safety Info
For OPDIVO® Treatment.
- See Approved Indications
Explore The Indications For FDA
Approved Treatment Option OPDIVO®.
- Prep & Admin Info
See Comprehensive Info For The
Prep & Administration Of OPDIVO®
- Info On Financial Support
Visit Access And Support Site
And View Other Patient Resources.
- Treatment Modifications
Find Dose Modifications To
Manage Adverse Reactions.
- View Dosing Schedules
Search results
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income...
Morningstar· 5 days agoThe Company enters strategic collaboration with the Access to Oncology Medicines (ATOM) Coalition to expand access to immuno-oncology therapy Opdivo™ in select countries PRINCETON, NJ / ACCESSWIRE ...
... Updated Action Date from the U.S. Food and Drug Administration for Subcutaneous Nivolumab...
Morningstar· 6 days agoUpdated Prescription Drug User Fee Act goal date of December 29, 2024 SAN DIEGO, May 21, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Bristol ...
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
Zacks via Yahoo Finance· 5 days agoBristol Myers Squibb BMY announced that the FDA will now decide on the biologics license application...
Lung cancer: Pre- and postsurgical immunotherapy may improve outcomes
Medical News Today· 6 days agoLung cancer is a major cause of all cancer-related deaths, with some treatment options involving...
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab...
FOX 4 Kansas City· 3 days agoThe study, which enrolled patients regardless of their CLDN18.2 and PD-L1 CPS expression, indicated...
Immunotherapy for stomach cancer: Types and effectiveness
Medical News Today· 4 days agoImmunotherapy may help shrink a tumor or slow the growth of cancer cells. People may have it in...
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WTNH-TV New Haven· 4 days agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting....
FDA sets new review date for Halozyme's drug delivery tech By Investing.com
Investing.com· 6 days agoFood and Drug Administration (FDA) has updated the Prescription Drug User Fee Act (PDUFA) goal date...
Ipswich man's small mole led to skin cancer and seven surgeries
BBC News· 1 day agoBack in 2012, John Cleeton could never have imagined that a mole, smaller than his little finger's...
From Robust Response to Rapid Resistance
MedPage Today· 3 days agoThe cancer treatment landscape dramatically changed since the first approval of an immune checkpoint inhibitor (ICI), ipilimumab, a CTLA-4 inhibitor, in...
Ad
related to: nivolumab
